Sector
PharmaceuticalsOpen
₹44.3Prev. Close
₹42.3Turnover(Lac.)
₹0.88Day's High
₹44.3Day's Low
₹44.352 Week's High
₹69.4552 Week's Low
₹40.5Book Value
₹0Face Value
₹10Mkt Cap (₹ Cr.)
41.6P/E
37.43EPS
1.13Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 4.7 | 4.54 | 4.54 | 3.34 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 8.64 | 6.78 | 6.49 | 1.44 |
Net Worth | 13.34 | 11.32 | 11.03 | 4.78 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Dec-2020 | Mar-2020 |
---|---|---|---|
Revenue | 6.06 | 1.42 | 16.71 |
yoy growth (%) | 325.6 | -91.46 | |
Raw materials | -4.27 | -0.87 | -10.61 |
As % of sales | 70.41 | 61.16 | 63.48 |
Employee costs | -0.79 | -0.06 | -2.56 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Dec-2020 |
---|---|---|
Profit before tax | 0.16 | 0.3 |
Depreciation | -0.11 | -0.02 |
Tax paid | -0.01 | -0.07 |
Working capital | 0.57 | |
Other operating items |
Y/e 31 Mar | Mar-2021 | Dec-2020 |
---|---|---|
Growth matrix (%) | ||
Revenue growth | 325.6 | |
Op profit growth | 20.8 | |
EBIT growth | -3.64 | |
Net profit growth | -33.76 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Gross Sales | 62.52 | 35.14 | 26.76 | 6.07 |
Excise Duty | 0 | 0 | 0 | 0 |
Net Sales | 62.52 | 35.14 | 26.76 | 6.07 |
Other Operating Income | 0 | 0 | 0 | 0 |
Other Income | 0.22 | 0.34 | 0.04 | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,698.35 | 129.24 | 4,07,155.15 | 1,181.05 | 0.8 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,549.7 | 71.05 | 1,47,295.24 | 594 | 0.54 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,444.25 | 25.07 | 1,16,664.33 | 1,438.15 | 0.9 | 4,134.87 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183.9 | 59.03 | 1,07,673.27 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,458.1 | 52.42 | 1,01,358.17 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Kalpesh Pravinchandra Ladhawala
Whole-time Director
Tanmaykumar Ashwinbhai Shah
Executive Director
Sejal Ladhawala
Executive Director
Abhishekkumar Dineshkumar Patel
Executive Director
Fenil Prakashkumar Sha
Executive Director
Jigneshkumar Dineshkumar Modi
Executive Director
Krunal Jashubhai Patel
Executive Director
Nidhi YogeshKumar Shah
Executive Director
Divyanshu Subhashchandra Raval
Addtnl Non-Exe Dir &Indpnt Dir
Jayshukh Ramjibhai Detroja
Addtnl Non-Exe Dir &Indpnt Dir
Rupesh Himatla Shah
Addtnl Non-Exe Dir &Indpnt Dir
Tapan Natverlal Patel
Addtnl Non-Exe Dir &Indpnt Dir
Nehalkumar Jasvantlal Shah
Company Secretary
Priyanka Shah
Independent Director
Megha Shah
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Walpar Nutritions Ltd
Summary
Walpar Nutritions Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of M/s Walpar Healthcare, pursuant to a Deed of Partnership dated November 16, 2009. Subsequently, the Constitution of Partnership Firm were changed on March 9, 2015, August 15, 2017 and June 12, 2020 by admission and retirement of Partners. M/s. Walpar Healthcare was thereafter incorporated and converted from a erstwhile Partnership Firm to a Public Limited Company in the name of Walpar Nutritions Limited and received a Certificate of Incorporation dated December 4, 2020 from the Central Registration Center, Ministry of Corporate Affairs. The Company is primarily engaged in manufacturing, marketing and trading of Pharmaceuticals, Nutraceutical, Herbal and Ayurvedic commodities online and offline.The Company made a public issue of 12,00,000 Equity Shares of having Face Value of Rs. 10/- each by raising funds aggregating to Rs. 6.60 Crore in July, 2021. Company initiated its journey as partnership firm namely M/s. Walpar Healthcare at Naranpura, Ahmedabad. Initially, it had commenced with the marketing of Ayurvedic Cosmetics and Herbal items. In 2014, it got the manufacturing license of FSSAI license (Food Safety and Standards Authority of India) and commence manufacturing of Nutraceutical products for third party at Hathijan, Ahmedabad. In 2015-16, it shifted the manufacturing facilities at Santej, in Gandhinagar. By the year end 2015-16,
Read More
The Walpar Nutritions Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹44.3 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Walpar Nutritions Ltd is ₹41.60 Cr. as of 01 Apr ‘25
The PE and PB ratios of Walpar Nutritions Ltd is 37.43 and 2.98 as of 01 Apr ‘25
The 52-week high/low is the highest and lowest price at which a Walpar Nutritions Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Walpar Nutritions Ltd is ₹40.5 and ₹69.45 as of 01 Apr ‘25
Walpar Nutritions Ltd's CAGR for 5 Years at 8.22%, 3 Years at 45.51%, 1 Year at -19.63%, 6 Month at -14.37%, 3 Month at -16.24% and 1 Month at -8.14%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.